Neuropsychological dysfunction associated with cancer and cancer therapies: a conceptual review of an emerging target
- PMID: 15150608
- PMCID: PMC2410277
- DOI: 10.1038/sj.bjc.6601772
Neuropsychological dysfunction associated with cancer and cancer therapies: a conceptual review of an emerging target
Abstract
Neuropsychological dysfunction associated with cancer and cancer treatment is a growing concern. Methodological limitations permeate the corpus of research in this area and have limited our understanding of the multifactorial nature of this process. The following review provides a summary of the current state of knowledge and highlights future directions.
Figures
References
-
- Anderson-Hanley C, Sherman ML, Riggs R, Agocha VB, Compas BE (2003) Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature. J Int Neuropsychol Soc 9: 967–982 - PubMed
-
- Armstrong CL, Goldstein B, Shera D, Ledakis GE, Tallent EM (2003) The predictive value of longitudinal neuropsychologic assessment in the early detection of brain tumor recurrence. Cancer 97: 649–656 - PubMed
-
- Capuron L, Ravaud A, Dantzer R (2001) Timing and specificity of the cognitive changes induced by interleukin-2 and interferon-alpha treatments in cancer patients. Psychosom Med 63: 376–386 - PubMed
-
- Cherrier MM, Asthana S, Plymate S, Baker L, Matsumoto AM, Peskind E, Raskind MA, Brodkin K, Bremmer W, Petrova A, LaTendresse S, Craft S (2001) Testosterone supplementation improves spatial and verbal memory I healthy older men. Neurology 57: 80–89 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
